Weill M M - OmicsDI

Show results for

Unknown (8896)
Proteomics (69)
Genomics (30)
Transcriptomics (19)
Metabolomics (9)
Genomic (4)
Models (1)
Other (1)

Organisms

Homo sapiens (45)
Mus musculus (26)
Saccharomyces cerevisiae (8)
Salmo salar (3)
Rattus (1)
Ciona intestinalis (1)
Malus domestica (1)
Schizosaccharomyces pombe (1)
Arabidopsis thaliana (1)
Chlorocebus sabaeus (1)
Cytomegalovirus (1)
Ixodes scapularis (1)
Mycobacterium tuberculosis (1)
Ovis aries (1)
Rattus norvegicus (1)
Severe acute respiratory syndrome coronavirus 2 (1)

Organisms

Mus musculus (11)
Mycobacterium tuberculosis H37Rv (4)
Homo sapiens (3)
Mycobacterium tuberculosis (1)

Repository

pride (64)
ENA (25)
biostudies-arrayexpress (22)
MetaboLights (7)
MassIVE (5)
dbGaP (4)
EGA (2)
MetabolomicsWorkbench (2)
BioModels (1)
GPMDB (1)

Tissue

Cell culture (19)
Brain (5)
Dendritic cell (5)
Epithelial cell (4)
Kidney (4)
Lung (4)
Blood plasma (3)
Fibroblast (3)
Lymph (3)
Blood serum (2)
Bone marrow (2)
Embryonic stem cell (2)
Permanent cell line cell (2)
Spleen (2)
Stem cell (2)
Blood (1)
Liver (1)
Astrocyte (1)
B cell (1)
Bile (1)
Bile duct (1)
Blood cell (1)
Blood-lymph (1)
Breast (1)
Cartilage (1)
Colon (1)
Conventional dendritic cell (1)
Endothelial cell of lymphatic vessel (1)
Ependymal cell (1)
Flower bud (1)

Disease

Breast cancer (4)
Colon cancer (3)
Disease free (3)
Prostate adenocarcinoma (3)
Acute leukemia (2)
Brain cancer (2)
Inflammatory bowel disease (2)
Lung cancer (2)
Melanoma (2)
Obesity (2)
Not Available (1)
Cancer (1)
Fatty liver disease (1)
Alzheimer's disease (1)
Amyotrophic lateral sclerosis (1)
COVID-19 (1)
Childhood extraosseous osteosarcoma (1)
Cholangiocarcinoma (1)
Chronic bronchitis (1)
Chronic lymphocytic leukemia (1)
Disease of metabolism (1)
Embryonal rhabdomyosarcoma (1)
Fibrosarcoma (1)
Head and neck cancer (1)
Inflammatory bowel disease 1 (1)
Kidney cancer (1)
Lung carcinoma (1)
Malignant mesothelioma (1)
Mucinous pancreas adenocarcinoma (1)
Neuroblastoma (1)

Technology Type

Mass Spectrometry (66)
Shotgun proteomics (28)
Data-dependent acquisition (13)
Affinity purification coupled with mass spectrometry proteomics (11)
Bottom-up proteomics (10)
Gel-based experiment (8)
Mass spectrometry (6)
SWATH MS (4)
Data-independent acquisition (3)
Top-down proteomics (3)
ESI (2)
Mass spectrometry assay (1)
All-ion fragmentation (1)

Instrument Platform

Illumina NovaSeq 6000 (4)
Liquid Chromatography MS - negative - reverse phase (4)
MA900, Sony (2)
10x Chromium Controller (2)
NextSeq 500 (2)
Orbitrap Fusion (2)
Q Exactive (2)
LTQ Orbitrap Discovery (Thermo Scientific) (2)
Illumina MiSeq (1)
NextSeq 550 (1)
Illumina HiSeq 2000 (1)
Instrument (1)
LTQ Orbitrap Velos (1)
Q Exactive HF (1)
Liquid Chromatography MS - negative - hilic (1)
Liquid Chromatography MS - positive - hilic (1)
Liquid Chromatography MS - positive - reverse phase (1)

Publication Date

2021 (13)
2025 (12)
2024 (11)
2019 (9)
2017 (9)
2026 (9)
2022 (7)
2023 (6)
2015 (5)
2014 (5)
2020 (5)
2013 (4)
2016 (2)
2005 (1)
2018 (1)

CHEBI ID

CHEBI:17596 (5)
CHEBI:16027 (4)
CHEBI:30769 (4)
CHEBI:15428 (3)
CHEBI:15741 (3)
CHEBI:17509 (3)
CHEBI:17752 (3)
CHEBI:17754 (3)
CHEBI:27897 (3)
CHEBI:30915 (3)
CHEBI:37024 (3)
CHEBI:82914 (3)
CHEBI:131434 (2)
CHEBI:132983 (2)
CHEBI:132996 (2)
CHEBI:133028 (2)
CHEBI:133032 (2)
CHEBI:133086 (2)
CHEBI:133148 (2)
CHEBI:133181 (2)
CHEBI:133183 (2)
CHEBI:133185 (2)
CHEBI:133508 (2)
CHEBI:133532 (2)
CHEBI:133542 (2)
CHEBI:133677 (2)
CHEBI:1372 (2)
CHEBI:1427 (2)
CHEBI:14336 (2)
CHEBI:15344 (2)

Metabolite Name

Inosine (3)
1-methylguanidine (2)
1-methylhistidine (2)
1-methylnicotinamide (2)
1-methylurate (2)
2-aminoadipate (2)
2-aminobutyrate (2)
2-aminoheptanoate (2)
2-hydroxyglutarate (2)
2-methylbutyrylcarnitine (C5) (2)
2-piperidinone (2)
2-pyrrolidinone (2)
3-aminoisobutyrate (2)
3-hydroxybutyrate (BHBA) (2)
3-hydroxyisobutyrate (2)
3-methoxytyrosine (2)
3-methylcytidine (2)
3-methylglutarylcarnitine (2) (2)
3-ureidopropionate (2)
4-acetamidobutanoate (2)
4-guanidinobutanoate (2)
4-imidazoleacetate (2)
5-acetylamino-6-amino-3-methyluracil (2)
5-acetylamino-6-formylamino-3-methyluracil (2)
5-hydroxylysine (2)
5-methylthioadenosine (MTA) (2)
7-methylguanine (2)
7-methylxanthine (2)
Alpha-ketoglutarate (2)
N-acetyl-1-methylhistidine* (2)

First Public Date

2024 (6)
2025 (3)
2021 (3)
2014 (3)
2013 (3)
2020 (2)
2026 (1)
2023 (1)
2019 (1)
2016 (1)
2015 (1)

Modelling Approach

Ordinary differential equation model (1)

Lab affiliation

Department of Biochemistry and Functional Proteomics, Institute of Biology II, Faculty of Biology and BIOSS Centre for Biological Signalling Studies, University of Freiburg, 79104 Freiburg im Breisgau, Germany (5)
Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA (3)
Weill Cornell Medical College (3)
Weill Cornell Medical College in Qatar (2)
Weill Cornell Medical College, New York City (2)
Weill Cornell Medicine - Qatar (2)
1) Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York, 10065, USA. 2) Pharmacology Program of the Weill Cornell Graduate School of Medical Sciences, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA. 3) Tri-Institutional PhD Program in Chemical Biology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA. (1)
Appel Alzheimer's Disease Research Institute & Brain and Mind Research Institute Weill Cornell Medicine New York, NY USA (1)
Appel Alzheimer's Disease Research Institute Feil Family Brain and Mind Research Institute Weill Cornell Medicine New York, NY 10021 (1)
Assistant Professor of Neurosurgery Department of Neurosurgery Houston Methodist Research Institute Weill Cornell Medical College (1)
Associate Professor, Neurology UCSF Weill Institute for Neurosciences School of Medicine University of California, San Francisco (1)
Dana-Farber Cancer Institute (1)
Department of Chemistry and Chemical Biology, Weill Institute for Cell and Molceular Biology, Cornell University, US (1)
Department of Computational Biology Weill Institute for Cell and Molecular Biology Center for Innovative Proteomics Cornell University (1)
Department of Medicine, Weill Cornell Medical College (1)
Department of Medicine, Weill Cornell Medicine, New York, NY, USA (1)
Department of Microbiology and Immunology University of Maryland School of Medicine USA (1)
Department of Molecular Biology and Genetics, Weill Institute for Cell and Molecular Biology, Cornell University, Ithaca, NY 14853 (1)
Department of Neurology and Weill Institute for Neurosciences, University of California, San Francisco (1)
Department of Pathology and Laboratory Medicine, The Joan and Stanford I. Weill Medical College of Cornell University, New York, NY 10065, USA (1)
Department of Pathology, University of California, San Francisco. San Francisco, CA, USA. Institute for Neurodegenerative Diseases, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA. (1)
Department of Pediatrics, Weill Cornell Medicine, New York, NY, USA (1)
Department of Radiation Oncology, Weill Cornell Medicine, New York, NY, 10065, USA (1)
Department of Radiation Oncology, Weill Cornell Medicine, New York, NY, USA; Department of Pathology, University of Massachusetts Medical School, Worcester, MA, USA. (1)
Department of Urology, SUNY Upstate Medical University (1)
Department of Urology, SUNY Upstate Medical University Syracuse, NY 13210, USA (1)
Department: Radiation Oncology; Weill Cornell Medicine: Englander Institute of Precision Medicine; USA. (1)
Departments of Pharmacology and Biochemistry and the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine (1)
Division of Pulmonary and Critical Care Medicine Weill Cornell Medicine (1)
Englander Institute of Precision Medicine Professor Radiation Oncology Professor Physiology and Biophysics Weill Cornell Medicine 1300 York Avenue Room E215 New York, NY 10065 (1)